MaDOx
Monitoring & Diagnosis
Missed diagnoses cause substantial and unnecessary morbidity, mortality and costs; likewise inappropriate or unnecessary diagnostic investigations waste resources. Our diagnostic research programme is designed to help front-line clinicians make better decisions, particularly in the areas of children’s health and cardiovascular disease.
Monitoring of patients who have chronic diseases is increasingly important. The MaDOx programme is identifying better and more cost-effective ways of monitoring treatment and progress of patients with diseases such as hypertension, heart failure, diabetes, asthma, and those on anticoagulation therapy.
The Oxford Diagnostic Horizon Scanning Programme
The Oxford Horizon Scanning Programme identifies new and emerging diagnostic technologies which may be relevant to primary care in the NHS. We use a variety of methods to search for these new technologies (including biochemical point of care tests, electronic diagnostic equipment, clinical prediction rules), and prioritise certain technologies to produce horizon scanning reports, systematic reviews and health economic assessments. The aim of the horizon scanning reports is to summarise why this new technology is important and what next steps are needed to help decide whether it should be adopted in the UK. These reports are made freely accessible on our website and are used by various NHS organisations (e.g. Health Technology Assessment Programme and NHS commissioning bodies) to provide them with this key information. The priorities of this programme are Cardiovascular Disease, Cancer and Infection.
Collaborators
University of Birmingham
Prof David Fitzmaurice - Professor of Primary Care Research
Dr Richard McManus - Senior Lecturer
Dr. Claire Packer - National Horizon Scanning Centre; Public Health, Epidemiology and Biostatistics
Dr. Luan Linden-Phillips - National Horizon Scanning Centre; Public Health, Epidemiology and Biostatistics
University of Leicester
Dr Monica Lakanpaul - Senior Lecturer in Child Health
Belgium
Prof Frank Buntinx - Katholieke Universiteit Leuven
Dr Ann Van den Bruel - Katholieke Universiteit Leuven
The Netherlands
Prof Henriette Moll - Erasmus MC - Sophia, Rotterdam
Dr Rianne Oostenbrink - Erasmus MC - Sophia, Rotterdam
Spain
Pablo Alonso Coello - Centro Cochrane Iberoamericano
Josep Garcia Alamino - DPhil Student
Patient Representatives
Eve Knight - Anticoagulation Europe
Christian Schaefer - ISMAAP

